HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tae-Yoon Kim Selected Research

Tae-Yoon Kim Research Topics

Disease

26Inflammation (Inflammations)
03/2022 - 09/2006
20Psoriasis (Pustulosis Palmaris et Plantaris)
10/2017 - 03/2003
13Neoplasms (Cancer)
01/2018 - 08/2002
12Atopic Dermatitis (Atopic Eczema)
03/2022 - 01/2007
10Skin Diseases (Skin Disease)
02/2021 - 01/2007
5Asthma (Bronchial Asthma)
03/2022 - 04/2012
5Melanoma (Melanoma, Malignant)
02/2021 - 10/2009
4Hyperplasia
01/2017 - 09/2006
4Hypoxia (Hypoxemia)
08/2015 - 10/2007
3Erythema
02/2021 - 03/2006
2Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
03/2022 - 01/2017
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 08/2015
2Wounds and Injuries (Trauma)
01/2020 - 09/2017
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 10/2015
2Cardiovascular Diseases (Cardiovascular Disease)
10/2015 - 03/2013
2Pathologic Neovascularization
08/2015 - 01/2008
2Carcinogenesis
10/2014 - 10/2009
2Dermatitis
03/2014 - 07/2011
2Ischemia
03/2013 - 08/2012
2Atherosclerosis
08/2012 - 04/2012
2Vascular Diseases (Vascular Disease)
08/2012 - 12/2011
2Edema (Dropsy)
09/2010 - 09/2006
2Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2003 - 12/2002
1Parasitic Diseases (Parasitic Disease)
03/2022
1Diabetes Mellitus
01/2022
1Candidiasis (Moniliasis)
12/2021
1Constipation
08/2021
1Colitis
06/2021
1Skin Neoplasms (Skin Cancer)
02/2021
1Hypersensitivity (Allergy)
02/2021
1Tonsillar Neoplasms
01/2021
1Bacteremia
01/2020
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2018

Drug/Important Bio-Agent (IBA)

19Superoxide DismutaseIBA
03/2022 - 09/2006
11CytokinesIBA
06/2021 - 01/2007
8Proteins (Proteins, Gene)FDA Link
06/2021 - 10/2003
6Immunoglobulin E (IgE)IBA
03/2022 - 01/2007
6ChemokinesIBA
03/2017 - 07/2007
5OvalbuminIBA
03/2022 - 11/2012
4Biological ProductsIBA
01/2018 - 11/2003
4Imiquimod (Aldara)FDA LinkGeneric
10/2017 - 02/2016
4AntioxidantsIBA
03/2016 - 12/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015 - 08/2002
4EnzymesIBA
02/2015 - 12/2011
3Mitogen-Activated Protein KinasesIBA
06/2021 - 01/2017
3Leucine (L-Leucine)FDA Link
01/2020 - 01/2017
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018 - 04/2003
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 05/2010
3NF-kappa B (NF-kB)IBA
02/2016 - 04/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
02/2016 - 09/2010
3capsiateIBA
08/2015 - 01/2008
3DNA (Deoxyribonucleic Acid)IBA
04/2014 - 03/2003
2Streptozocin (Streptozotocin)FDA Link
01/2022 - 08/2015
2Retinaldehyde (Retinal)IBA
01/2022 - 08/2015
2alpha-MSHIBA
02/2021 - 10/2009
2CPG-oligonucleotideIBA
02/2021 - 07/2007
2OligodeoxyribonucleotidesIBA
02/2021 - 12/2002
2Interleukin-4 (Interleukin 4)IBA
02/2021 - 11/2007
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2020 - 10/2015
2Arginine (L-Arginine)FDA Link
01/2020 - 10/2015
2Amino AcidsFDA Link
01/2020 - 10/2015
2Interleukin-23 (Interleukin 23)IBA
03/2017 - 04/2013
2Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2017
2rhododendrinIBA
01/2017 - 08/2013
2Janus KinasesIBA
02/2016 - 07/2015
2Oxygen (Dioxygen)IBA
08/2015 - 12/2011
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2015 - 07/2015
2InterleukinsIBA
03/2014 - 10/2003
2Transcription Factors (Transcription Factor)IBA
05/2012 - 10/2007
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2011 - 09/2006
2Interleukin-10 (Interleukin 10)IBA
12/2011 - 11/2007
2Melanins (Melanin)IBA
08/2011 - 10/2009
2src-Family KinasesIBA
05/2010 - 04/2004
2Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2007 - 04/2004
1secukinumabIBA
12/2021
1Irritants (Vesicants)IBA
08/2021
1Dietary FiberFDA Link
08/2021
1PrebioticsIBA
08/2021
1Dextran SulfateIBA
06/2021
1Cadherins (E-Cadherin)IBA
06/2021
1Melanocyte-Stimulating Hormones (MSH)IBA
02/2021
1ArgonIBA
02/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
1PyrinIBA
01/2020
1PAR-2 ReceptorIBA
01/2020
1Heparin (Liquaemin)FDA LinkGeneric
01/2020
1NucleotidesIBA
01/2020
1Therapeutic UsesIBA
12/2018
1Protein Kinases (Protein Kinase)IBA
10/2018
1Adenosine Monophosphate (AMP)IBA
10/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2018
1Peptidoglycan (Murein)IBA
01/2018
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2018

Therapy/Procedure

8Therapeutics
01/2020 - 10/2003
3Subcutaneous Injections
01/2020 - 09/2011
2Immunotherapy
12/2012 - 12/2002
2Radiotherapy
12/2012 - 03/2006
2Drug Therapy (Chemotherapy)
12/2012 - 11/2003
1Critical Care (Surgical Intensive Care)
01/2020
1Length of Stay
01/2020